FDA Recommends Leaving COX-2 Drugs On Market

On Feb. 18, an FDA panel decided that COX-2 drugs such as Vioxx and Celebrex should remain on the market, despite the heart concerns.
I don't understand why they would advise this. Has it not already been shown that these drugs pose serious heart risks to users? According to the NY Times's article, the drugs would remain on the market though all advertising would be pulled. The recommendation to leave the drugs on the market came after a narrow passing of Vioxx and Bextra, while fully backing Celebrex to stay available.
Not surprisingly Pfizer and Merck stock gained quite a few points. FDA = crooked? If they all voted to ban the drugs and thereby surely crush the companies' share prices, would the FDA have been affected? (ahem, under the table deals?)

Just weird. :\

They're dangerous, but they offer some very useful benefits as well.  The way I see it, we ought to leave them on the market, along with appropriate warnings so that informed patients and doctors can make the cost benefit analysis themselves.